glp-1 agonists and sglt2 inhibitors combination GLP1 Receptor vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Blood pressure effects of SGLT2

Fiber Managing the Most Common GLP-1 Side Effect Why it matters: Constipation is the most persistent long-term GI side effect of GLP-1 medications

b , Mouse brain images showing heatmap of averaged changes in cFOS expression in response to treatments relative to vehicle

Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Twitter summary: @LillyDiabetes launches Trulicity in the US first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10, Eli Lilly and company announced that Trulicity (dulaglutide) is now available in the US, making it the first ready-to-use once weekly GLP-1 receptor agonist to reach the market (no mixing required)

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

These medications include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), and dulaglutide (Trulicity for diabetes only)